Cancer in Norway
Cancer in Norway 2023
Cancer in Norway 2022
Cancer in Norway 2021
- Cancer in Norway 2021(pdf)
- Special Issue 2021: Cancer survival in Norway 1965–2021: Extending standard reporting to improve communication of survival statistics(pdf)
- Cancer in Norway 2021 with Special Issue(pdf)
- Technical Supplement: Statistical methods(pdf)
Cancer in Norway 2020
- Cancer in Norway 2020(pdf)
- Special Issue 2020: Kreft i Norge- hva sier tallene?(pdf)
- Technical Supplement: Statistical Methods(pdf)
Cancer in Norway 2019
Cancer in Norway 2018
- Cancer in Norway 2018(pdf)
- Cancer in Norway and Special Issue2018(pdf)
- Special Issue - Sosial ulikhet, innvandring og kreft(pdf)
- Technical Supplement: Statistical Methods(pdf)
Cancer in Norway 2017
Cancer in Norway 2016
- Cancer in Norway 2016(pdf)
- Cancer in Norway 2016 with Special Issue(pdf)
Cancer in Norway 2016 - Special Issue(pdf) - Technical Supplement: Statistical Methods(pdf)
- Kreft i Norge 2016- sammendrag(pdf)
- PDF figurer til nett
Low-res
- Kreft i Norge 2016- sammendrag(pdf)
- Cancer in Norway 2016(pdf)
- Cancer in Norway 2016 - Special Issue low-res(pdf)
Cancer in Norway 2015
- Cancer in Norway 2015(pdf)
- Cancer in Norway 2015 - Norsk sammendrag(pdf)
- Cancer in Norway 2015 del 1+2(pdf)
- Cancer in Norway 2015 del 1(pdf)
- Cancer in Norway 2015 - Special Issue(pdf)
- Technical Supplement: Statistical Methods(pdf)
Low-res
- Cancer in Norway 2015 del 1+2- low-res(pdf)
- Cancer in Norway 2015 del 1 low-res(pdf)
- Cancer in Norway 2015 - Special Issue low-res(pdf)
Cancer in Norway 2014
- Cancer in Norway 2014 norsk sammendrag(pdf)
- Cancer in Norway 2014 del 1+2(pdf)
- Cancer in Norway 2014 del 1(pdf)
- Cancer in Norway 2014- Special Issue del 2 Catch-HPV(pdf)
- Technical Supplement: Statistical Methods(pdf)
Cancer in Norway 2013
- Cancer in Norway 2013 del 1+2(pdf)
- Cancer in Norway 2013 (low-res) del 1+2(pdf)
- Cancer in Norway 2013 del 1(pdf)
- Cancer in Norway (low-res) del 1(pdf)
- Cancer in Norway 2013-Special Issue del 2 kreft i Norges fylker 1954-2013(pdf)
- Cancer in Norway 2013-Special Issue (low-res) del 2 kreft i Norges fylker 1954-2013(pdf)
Cancer in Norway 2012
Cancer in Norway 2011
- Cancer in Norway 2011(146 sider)(pdf)
- Cancer in Norway 2011 (low-res)(pdf)
- Cancer in Norway - Del 1 (pdf 90 sider)(pdf)
- Cancer in Norway - Del 1 (low-res)(pdf)
- Cancer in Norway - Del 2 Special Issue (pdf 56 sider)(pdf)
- Cancer in Norway - Del 2 Special Issue (low-res)(pdf)
Cancer in Norway 2010
- Cancer in Norway 2010(133 sider)(pdf)
- Cancer in Norway - Del 1(102 sider)(pdf)
- Cancer in Norway - Del 2 Special Issue(31 sider)(pdf)
Cancer in Norway 2009
- Cancer in Norway 170 sider)(pdf)
- Cancer in Norway -del 1(98 sider)(pdf)
- Special Issue(72 sider)(pdf)
Cancer in Norway 2008
- Del 1: Cancer in Norway 2008(pdf)
- Del 2: The Janus Serum Bank - From sample collection to cancer research(pdf)
- Cancer in Norway 2008 (hele publikasjonen)(pdf)
Cancer in Norway 2007
- Del 1: Cancer in Norway 2007(pdf)
- Del 2: Long-term cancer survival: Patterns and trends in Norway 1965–2007(pdf)
- Cancer in Norway 2007 (hele publikasjonen)(pdf)
Cancer in Norway 2006
- Cancer in Norway 2006(pdf)
- Cancer in Norway 2006 special issue(pdf)
- NB! Erratum til Special Issue(pdf)
Cancer in Norway 2005
- Del 1: Cancer in Norway 2005(pdf)
- Del 2: Predictions of cancer incidence by Health Region 2010-2020(pdf)
- Cancer in Norway 2005 (hele publikasjonen)(pdf)
- Part 3 - Selected sites (graphics)(pdf)
- New cases and incidence rates for each county (tables)(pdf)
Erratum for cancer in Norway
Erratum for cancer in Norway 2015
The Cancer in Norway reports from 2015 to 2018 contained an error in staging of cervical cancer. Stage, as reported by the clinician, was not used in this period due to an error in mapping from electronic clinical reporting. The traditional staging (localized stage, regional stage, distant stage and unknown) with in-house conversion to FIGO staging was used instead. This caused too high survival estimates for stage IV.
Erratum for cancer in Norway 2016
The Cancer in Norway reports from 2015 to 2018 contained an error in staging of cervical cancer. Stage, as reported by the clinician, was not used in this period due to an error in mapping from electronic clinical reporting. The traditional staging (localized stage, regional stage, distant stage and unknown) with in-house conversion to FIGO staging was used instead. This caused too high survival estimates for stage IV.
Erratum for Cancer in Norway 2017
The Cancer in Norway reports from 2015 to 2018 contained an error in staging of cervical cancer. Stage, as reported by the clinician, was not used in this period due to an error in mapping from electronic clinical reporting. The traditional staging (localized stage, regional stage, distant stage and unknown) with in-house conversion to FIGO staging was used instead. This caused too high survival estimates for stage IV.
Erratum for Cancer in Norway 2018
The Cancer in Norway reports from 2015 to 2018 contained an error in staging of cervical cancer. Stage, as reported by the clinician, was not used in this period due to an error in mapping from electronic clinical reporting. The traditional staging (localized stage, regional stage, distant stage and unknown) with in-house conversion to FIGO staging was used instead. This caused too high survival estimates for stage IV.
In 2018 we introduced a separate topography to identify cases (n = 50) with uncertain topography but most likely originating from tube, ovary or peritoneum and thereby considered as ovarian cancer. These cases were inadvertently included under C68 (malignant neoplasm of other and unspecified urinary organs). In Cancer in Norway 2019 these cases are included correctly under Ovary etc.
